Noctrix Health
Early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Launch date
Employees
Market cap
-
Enterprise valuation
€145—218m (Dealroom.co estimates Jan 2024.)
Pleasanton California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Series A | |
N/A | N/A | Early VC | |
$17.0m | Series B | ||
* | $40.0m | Series C | |
* | N/A | Debt | |
Total Funding | €51.8m |
Related Content
Recent News about Noctrix Health
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.